Top compounds associated with response to LINC01125


Feature Type Standardized
Nominal ANOVA
mRNA ifosfamide CTRPv2 pan-cancer AAC 0.14 0.01
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.01
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.09 0.01
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.091 0.01
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.099 0.01
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.01
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.01
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.01
mRNA RITA CTRPv2 pan-cancer AAC 0.088 0.01
mRNA Docetaxel gCSI pan-cancer AAC -0.13 0.01
Download CSV